◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › C › CYH

Community Health Systems Inc (CYH) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL CARE FACILITIES · DATA UPDATED 2026-11-02

Community Health Systems Inc (CYH) operates in the MEDICAL CARE FACILITIES industry and is headquartered in Franklin, United States with about 44,000 employees. Its market capitalization is roughly $338 million. In the fiscal year ended 2025-12-31, CYH reported $12.5B in revenue and $509M in net income.

Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States.

Interactive charts & full statements → Open the CYH valuation workbench →

CYH Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-09-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$11.7B$12.5B$12.6B$12.5B$12.2B$12.4B$11.8B$13.2B$14.2B$15.4B$18.4B$19.4B$18.6B$13.0B$13.0B$11.9B$11.4B$12.1B$10.8B$7.1B$4.4B
Gross Profit$10.0B$1.1B$5.3B$5.1B$4.9B$5.1B$4.4B$5.1B$5.4B$5.3B$6.8B$7.4B$7.2B$4.7B$4.9B$10.1B$9.6B$5.6B$5.0B$3.3B$2.1B
Gross Margin %85.5%8.7%41.7%40.7%40.2%41.1%37.5%38.7%38.3%34.5%36.9%38.1%38.4%36.4%37.5%84.6%84.5%46.1%46.1%46.1%48.4%
Operating Income (EBIT)$1.3B($9.9B)$542M$957M$821M$1.4B$1.1B$650M$208M($1.9B)($860M)$1.3B$1.3B$917M$1.2B$1.1B$1.1B$1.1B$984M$486M$380M
Operating Margin %10.9%-79.4%4.3%7.7%6.7%11.3%9.6%4.9%1.5%-12.2%-4.7%6.9%7.2%7.1%9.5%9.5%9.8%8.8%9.1%6.8%8.7%
Net Income$36M$509M($516M)($133M)$46M$230M$511M($590M)($788M)($2.5B)($1.7B)$158M$92M$141M$266M$202M$280M$243M$218M$30M$168M
Net Margin %0.3%4.1%-4.1%-1.1%0.4%1.9%4.3%-4.5%-5.6%-16.0%-9.3%0.8%0.5%1.1%2.0%1.7%2.5%2.0%2.0%0.4%3.9%
EBITDA—$2.0B$1.2B$1.3B$1.2B$1.7B$1.0B$1.4B$1.5B$899M$2.0B$2.4B$2.5B$1.7B$1.9B$1.8B$1.8B$1.7B$1.5B$824M$569M
Earnings Per Share (EPS)—$3.77$-3.91$-1.02$0.35$1.76$4.38$-5.19$-6.99$-22.00$-15.54$1.37$0.81$1.51$2.96$2.23$3.01$2.66$2.32$0.32$1.75
Shares Outstanding (M)—135M132M130M130M131M117M114M113M112M111M115M113M94M90M91M93M92M94M95M96M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CYH Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$4.1B$12.2B$3.1B$3.1B$3.1B$3.2B$3.3B$3.1B
Gross Profit$2.8B$11.7B($4.2B)$2.6B$1.3B$1.3B$1.4B$1.3B
Gross Margin %69.5%96.6%-134.6%85.1%42.7%41.1%42.7%40.8%
Operating Income (EBIT)$389M$1.6B($11.0B)$243M$512M$284M$278M($205M)
Operating Margin %9.6%13.5%-352.7%7.9%16.3%9.0%8.5%-6.6%
Net Income$70M($610M)$110M$130M$282M($13M)($70M)($391M)
Net Margin %1.7%-5.0%3.5%4.2%9.0%-0.4%-2.1%-12.7%
EBITDA$325M$3.7B$549M$322M$379M$365M$334M$178M
Earnings Per Share (EPS)$0.51$-4.52$0.81$0.96$2.09$-0.10$-0.53$-2.95
Shares Outstanding (M)136M135M135M135M135M133M132M132M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CYH Free Cash Flow History

Cash flowTTM → 2026-09-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$211M$543M$480M$210M$300M($131M)$2.2B$385M$274M$773M$1.1B$921M$1.6B$1.1B$1.3B$1.3B$1.2B$1.1B$1.1B$688M$350M
Capital Expenditures (CapEx)$333M$335M$360M$467M$415M$469M$440M$438M$527M$570M$867M$1.0B$853M$614M$769M$1.2B$667M$577M$692M$523M$225M
Free Cash Flow (FCF)($122M)$208M$120M($257M)($115M)($600M)$1.7B($53M)($253M)$203M$270M($89M)$762M$475M$511M$70M$521M$500M$365M$165M$126M
FCF Margin %-1.1%1.7%0.9%-2.1%-0.9%-4.9%14.7%-0.4%-1.8%1.3%1.5%-0.5%4.1%3.6%3.9%0.6%4.6%4.1%3.4%2.3%2.9%
Dividends Paid————$125M$121M$116M$99M$96M$100M$92M$100M$104M$76M$23M$0M$68M————

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CYH Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-09-302026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$154M$88M($297M)$266M$69M$88M$120M$216M$67M
Capital Expenditures (CapEx)$87M$76M$76M$94M$65M$91M$85M$109M$70M
Free Cash Flow (FCF)$67M$12M($373M)$172M$4M($3M)$35M$107M($3M)
FCF Margin %—0.3%-3.1%5.5%0.1%-0.1%1.1%3.3%-0.1%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CYH Balance Sheet History

Balance sheet2026-09-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$12.1B$13.2B$14.1B$14.5B$14.7B$15.2B$16.0B$15.6B$15.9B$17.4B$21.9B$26.9B$27.4B$17.1B$16.6B$15.2B$14.7B$14.0B$13.8B$13.5B$4.5B
Cash & Cash Equivalents$155M$260M$37M$38M$118M$507M$1.7B$216M$196M$563M$238M$184M$509M$373M$388M$130M$299M$345M$221M$133M$41M
Total Liabilities$13.0B$14.0B$15.4B$15.3B$15.4B$16.0B$17.1B$17.2B$16.8B$17.6B$19.7B$22.2B$22.8B$13.6B$13.4B$12.3B$12.1B$12.0B$11.8B$11.4B$2.8B
Total Debt (Short + Long-Term)$10.2B$10.5B$11.6B$11.6B$11.8B$12.3B$12.4B$13.5B$13.6B$13.9B$15.2B$16.8B$16.9B$9.5B$9.5B$8.8B$8.9B$8.9B$9.0B$9.1B$1.9B
Total Shareholders' Equity($1.5B)($1.4B)($1.9B)($1.4B)($1.4B)($1.4B)($1.6B)($2.2B)($1.5B)($767M)$1.6B$4.0B$4.0B$3.1B$2.7B$2.4B$2.2B$2.0B$1.7B$1.7B$1.7B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CYH viewer.

Other Companies in MEDICAL CARE FACILITIES

← CYGBAll “C” companiesCYIENT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.